PTC Other Non-Current Liabilities increased by 10.8% to $81.24M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.4%, from $64.81M to $81.24M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 27.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $53.81M | $49.69M | $46.89M | $46.09M | $42.37M | $35.83M | $33.35M | $32.87M | $33.13M | $39.81M | $42.82M | $41.80M | $40.49M | $63.83M | $61.62M | $64.81M | $72.69M | $187.91M | $73.32M | $81.24M |
| QoQ Change | — | -7.6% | -5.6% | -1.7% | -8.1% | -15.5% | -6.9% | -1.4% | +0.8% | +20.1% | +7.6% | -2.4% | -3.1% | +57.6% | -3.5% | +5.2% | +12.2% | +158.5% | -61.0% | +10.8% |
| YoY Change | — | — | — | — | -21.2% | -27.9% | -28.9% | -28.7% | -21.8% | +11.1% | +28.4% | +27.2% | +22.2% | +60.3% | +43.9% | +55.0% | +79.5% | +194.4% | +19.0% | +25.4% |